Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.

NCT01221480 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.

NCT NCT01221480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01221480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.
Lead sponsor
University of Dundee
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
October 31, 2010
Enrollment
5,977 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

copd